persons jointly manipulating the warrant price of NINE-W1. SEC Act (before the fifth amendment) Section 243 (1) in conjunction with 244 (1) (2) (3) Civil Action Dated 26/03/2018
persons jointly manipulating the warrant price of NINE-W1. SEC Act (before the fifth amendment) Section 243 (1) in conjunction with 244 (1) (2) (3) Civil Action Dated 26/03/2018
court SEC Act (the fifth amendment) Section 244/3 (1) Civil Action Dated 30/08/2018
executive at any issuing or listed companies for 1 year from 5 September 2018 to 4 September 2019. SEC Act (before the fifth amendment) Section 241 Civil Action Dated 24/09/2018
(before the fifth amendment), and , SEC Act (the fifth amendment) Section 241 and 242 (1) Civil Action Dated 30/07/2019
reimbursement of investigative expenses in an amount of 31,777.00 Baht SEC Act (the fifth amendment) Section 244/3 (2) Civil Action Dated 03/03/2023
currently under the state attorney process. SEC Act (the fifth amendment) Section 244/3 (2) Civil Action Dated 17/08/2023
Manufacture and sale of medicines, medical supplies and cosmetics segment 82,624 5.1 - - 82,624 100.0 รวม 1,614,607 100 1,637,162 100 (22,555) (1.4) In 2018, Sales and service revenue from the Company and its
5,346 0.8 Manufacture and sale of medicines, medical supplies and cosmetics segment 82,624 5.1 - - 82,624 100.0 รวม 1,614,607 100 1,637,162 100 (22,555) (1.4) In 2018, Sales and service revenue from the
5,346 0.8 Manufacture and sale of medicines, medical supplies and cosmetics segment 82,624 5.1 - - 82,624 100.0 รวม 1,614,607 100 1,637,162 100 (22,555) (1.4) In 2018, Sales and service revenue from the